Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total debt
Total debt on the balance sheet as of December 2023 : $0.67 B
According to Collegium Pharmaceutical 's latest financial reports the company's total debt is $0.67 B. A company’s total debt is the sum of all current and non-current debts.
Collegium Pharmaceutical - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.67 B | -4.92% |
| 2022-12-31 | $0.70 B | 174.08% |
| 2021-12-31 | $0.25 B | -2.94% |
| 2020-12-31 | $0.26 B | 1134.53% |
| 2019-12-31 | $21.59 M | 87.77% |
| 2018-12-31 | $11.5 M | 677.55% |
| 2017-12-31 | $1.47 M | -64.33% |
| 2016-12-31 | $4.14 M | -39.15% |
| 2015-12-31 | $6.81 M | -47.62% |
| 2014-12-31 | $13 M | 1236.79% |
| 2013-12-31 | $0.97 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | $0.70 B | 3.81% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.51 M | -99.63% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.55 B | 279.29% | 🇮🇪 Ireland |
 KemPharm KMPH | $23.11 M | -96.57% | 🇺🇸 USA |